DUBLIN–(BUSINESS WIRE)–The “Cannabis Pharmaceuticals Market Research Report by Brand, by Product Type, by Distribution Channel, by Application, by Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering.
The Global Cannabis Pharmaceuticals Market size was estimated at USD 872.57 million in 2020, is expected to reach USD 1,031.56 million in 2021, and is projected to grow at a CAGR of 18.58% to reach USD 2,877.64 million by 2027.
In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2027 are considered the forecast period.
Cumulative Impact of COVID-19:
The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects.
It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space.
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate.
- Increase in the legalization of medicinal cannabis in economies
- Growing awareness about the medical benefits of cannabidiol and its remedial properties
- Growing usage of cannabis-based pharmaceuticals for various indications such as inflammation, chronic pain, sleep disorders, and others
- High price associated with the medical cannabis
- Rise in investments by pharma companies in CBD and developments for cannabinoid regulation
- Innovation and launching new products
- Availability of various alternatives in the market
Company Usability Profiles:
- AbbVie Inc.
- Amyris, Inc.
- Aphria, Inc.
- Aurora Cannabis, Inc.
- Botanix Pharmaceuticals
- Breath of Life Pharma, Ltd.
- Cannabis Science, Inc.
- Canopy Growth Corporation
- Cara Therapeutics
- CB Therapeutics Inc.
- Corbus Pharmaceuticals Holdings, Inc.
- Cronos Group Inc.
- GW Pharmaceuticals, PLC
- Insys Therapeutics, Inc.
- Medical Marijuana Inc.
- Medicure Pharmaceuticals
- MedReleaf Corp.
- MGC Pharmaceuticals Limited
- Pascal Biosciences Inc.
- PharmaCyte Biotech, Inc.
- Serina Therapeutics, Inc.
- Teva Pharmaceutical Industries Ltd.
- Tilray, Inc.
- Valeant Pharmaceuticals
- Zynerba Pharmaceuticals, Inc.
Cannabis Pharmaceuticals Market, by Brand
Cannabis Pharmaceuticals Market, by Product Type
- Ointments & Creams
- Solids and Dissolvable Powder & Oil
Cannabis Pharmaceuticals Market, by Distribution Channel
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
Cannabis Pharmaceuticals Market, by Application
For more information about this report visit https://www.researchandmarkets.com/r/c7ks61
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900